RT Journal Article
SR Electronic
T1 SARS-CoV-2 Acquisition and Immune Pathogenesis Among School-Aged Learners in Four K-12 Schools
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.20.21254035
DO 10.1101/2021.03.20.21254035
A1 Dan M. Cooper
A1 Ilhem Messaoudi
A1 Shlomit Aizik
A1 Ricky L. Camplain
A1 Nanette V. Lopez
A1 Jessica Ardo
A1 Bernadette Boden-Albala
A1 Clayton Chau
A1 Curt Condon
A1 Charles Golden
A1 Izabela Coimbra Ibraim
A1 Allen Jankeel
A1 Kirsten Kasper
A1 Andria Meyer
A1 Annamarie Stehli
A1 Diana Stephens
A1 Michael Weiss
A1 Michael Z. Zulu
A1 Erlinda Ulloa
YR 2021
UL http://medrxiv.org/content/early/2021/03/26/2021.03.20.21254035.abstract
AB Objectives To directly measure SARS-CoV-2 infection in diverse schools with either remote or onsite learning.Methods 4 schools participated. Schools A and B served low-income Hispanic learners, school C special needs, and all three provided predominantly remote instruction. School D served middle and upper-middle income, White learners, with predominantly onsite instruction. 320 learners [10.5±2.1(SD); 7-17 y.o.]; 86% had phlebotomy. Testing occurred early in the fall (2020), at lower levels of COVID-19, and 6-8 weeks later during the fall-winter surge (tenfold increase in COVID-19 cases).Results Nasal RT-qPCR for SARS-CoV-2 and 21 respiratory pathogens was performed. Phlebotomy was obtained for circulating immunity. Face covering and physical distancing fidelity was measured by direct observation. 17 learners were SARS-CoV-2 positive during the surge. School A (97% remote) had the highest infection rate (9/70, 12.9%, p<0.01) and IgG positivity rate (13/70, 18.6%). School D had the lowest infection and IgG positive rate (1/86, 1.2%). Mitigation compliance [physical distancing (mean 87.4%) and face covering (91.3%)] was high at all schools. Learners with documented SARS-CoV-2 infection had neutralizing antibodies (94.7%), broad and robust IFN-γ+ T cell responses, reduced frequencies of monocytes, and lower levels of circulating inflammatory mediators.Conclusions Infection in the schools reflected regional rates rather than remote or onsite learning modalities. Schools can implement successful mitigation strategies across a wide range of income, school-type, and student diversity. Reduced monocyte and immune mediator concentrations coupled with robust humoral and cellular immunity may explain the generally milder symptoms in school-aged children.Table of Contents Summary SARS-CoV-2 infection and immunobiology was measured in children at 4 diverse schools with varying degrees of onsite and remote learning.What’s Known on This Subject At the start of the COVID-19 pandemic, schools were reflexively closed as there were fears that agreggation of school-aged children would lead to increased infection. Infectivity and immunobiology of SARS-CoV-2 in children attending schools not understood.What This Study Adds School-associated infections reflected regional rates rather than remote or onsite learning. Successful mitigation was implemented across a diverse range of schools. Reduced immune mediator concentrations coupled with robust humoral and cellular immunity may explain the milder symptoms in school-aged children.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNIH NCATS UCI Clinical and Translational Science Award UL1 TR001414; R01AI142841; R21AI143301; Orange County Health Care Agency Research Fund; UCI COVID-19 Research Fund; Support was provided in part by the Robert Wood Johnson Foundation to ERU.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the institutional review boards at the Childrens Hospital of Orange County and the University of California IrvineAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are openly available in medRxiv.CHOCChildren’s Hospital of Orange CountyOCHCAOrange County Health Care AgencySOCOMSystematic Observation of COVID-19 MitigationHDLhigh-density lipoproteinLDLlow-density lipoprotein